For Year 2025-26, SMS Pharmaceuticals reports the following shareholding: Total Promoters at 68.07%, Mutual Fund at 3.21%, Insurance at 0%, Foreign Institutional Investors at 0.04%, Domestic Institutional Investors at 0%, and Retail at 28.69%. This breakdown provides a quick snapshot of ownership distribution for SMS Pharmaceuticals in 2025-26.